NCT01399684 2016-08-26A Study Evaluating the Efficacy and Safety of MEGF0444A Dosed to Progression in Combination With Bevacizumab and mFOLFOX-6 in Participants With Previously Untreated Metastatic Colorectal CancerGenentech, Inc.Phase 2 Completed127 enrolled